Flavio de Alcantara Camejo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Flavio de Alcantara Camejo has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Luis Eduardo Almeida
Surgical Sciences Department, School of Dentistry, Marquette University, Milwakee, WI 53233, USA
8 shared publications - Andrea Doetzer
E School of Health and Bioscience, Pontifical Catholic University of Parana State , Curitiba , Brazil
4 shared publications - Lucia de Noronha
Departamento de Biologia Celular e Molecular e Patologia Experimental, Pontifícia Universidade Católica do Paraná, Curitiba 80215-901, PR, Brazil
4 shared publications - Paula Cristina Trevilatto
Pontifícia Universidade Católica do Paraná, Curitiba, Brazil, Brazil
4 shared publications A. Doetzer
3 shared publicationsAndrea Duarte Doetzer
Full Professor, School of Medicine, Pontifícia Universidade Católica do Paraná (PUCPR), Curitiba-PR, Brazil
3 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Wroclaw Medical University in Dental and Medical Problems
- Vol. 63 (5) , 1209-1214
Immunohistochemical expression of GRP78 in temporomandibular joint dysfunction
- 30 October 2026
- Published by Wroclaw Medical University in Dental and Medical Problems
- Vol. 63 (5) , 1209-1214
Open AccessImmunohistochemical expression of GRP78 in temporomandibular joint dysfunction
- 1 April 2021
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 131 (4) , e89-e94
Association of estrogen receptor alpha 1 and TMJ dysfunction: A pilot study
- 1 April 2021
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 131 (4) , e89-e94
Association of estrogen receptor alpha 1 and TMJ dysfunction: A pilot study
- 1 October 2020
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 78 (10) , e100
Correlation between FasL and IL-6 Expression in Human TMJ Disks with and without Osteoarthrosis
- 1 October 2020
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 78 (10) , e100
Correlation between FasL and IL-6 Expression in Human TMJ Disks with and without Osteoarthrosis
- Open Access
- 24 October 2019
- Published by MDPI AG in Applied Sciences
- Vol. 9 (21) , 4508
Matrix Metalloproteinases and Temporomandibular Joint Disorder: A Review of the Literature
Temporomandibular disorders (TMD) are progressive degenerative disorders that affect the components of the temporomandibular joint (TMJ), characterized by pain and limitations in function. Matrix metalloproteinases (MMP) are enzymes involved in physiological breakdown of tissue that can have a pathological effect from an increase in activity during inflammation. A PubMed search of the current literature (within the past 10 years) was conducted to identify human studies involving matrix metalloproteinases activity in TMJ components of patients with TMD. Two separate searches results in 34 studies, six of which met inclusion criteria. Immunohistochemistry and gene analysis were used to evaluate MMP expression in the study groups. This review showed the strongest evidence for involvement of MMP-1, MMP-2, and MMP-9 in TMD; however, limitations included low sample sizes and a lack of recent clinical studies. Future research with more definitive conclusions could allow for additional pharmaceutical targets in MMP when treating patients with temporomandibular disorders.
- 24 October 2019
- Published by MDPI AG in Applied Sciences
- Vol. 9 (21) , 4508
Open AccessMatrix Metalloproteinases and Temporomandibular Joint Disorder: A Review of the Literature
Temporomandibular disorders (TMD) are progressive degenerative disorders that affect the components of the temporomandibular joint (TMJ), characterized by pain and limitations in function. Matrix metalloproteinases (MMP) are enzymes involved in physiological breakdown of tissue that can have a pathological effect from an increase in activity during inflammation. A PubMed search of the current literature (within the past 10 years) was conducted to identify human studies involving matrix metalloproteinases activity in TMJ components of patients with TMD. Two separate searches results in 34 studies, six of which met inclusion criteria. Immunohistochemistry and gene analysis were used to evaluate MMP expression in the study groups. This review showed the strongest evidence for involvement of MMP-1, MMP-2, and MMP-9 in TMD; however, limitations included low sample sizes and a lack of recent clinical studies. Future research with more definitive conclusions could allow for additional pharmaceutical targets in MMP when treating patients with temporomandibular disorders.
- 1 October 2018
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 76 (10) , e77
Immunohistochemical Expression of RUNX2 in Condylar Hyperplasia
- 1 October 2018
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 76 (10) , e77
Immunohistochemical Expression of RUNX2 in Condylar Hyperplasia
- 1 October 2018
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 76 (10) , e79
Immunohistochemical Expression of IL1-R1 in the TMJ Disks
- 1 October 2018
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 76 (10) , e79
Immunohistochemical Expression of IL1-R1 in the TMJ Disks
- 25 March 2018
- Published by Taylor & Francis in Cranio®
- Vol. 37 (5) , 323-328
Immunohistochemical expression of TLR-4 in temporomandibular joint dysfunction
Toll-like receptor 4 (TLR-4) is a transmembrane protein involved in the innate immune system and has been implicated in the pathogenesis of temporomandibular joint dysfunction (TMD). The purpose of this study was to histologically examine the level of expression of TLR-4 relative to severity of TMD. Thirty-one human TMJ disc samples were immunostained for TLR-4 and evaluated for intensity of stain. Among the samples, 8 were control samples, 16 were from patients with anterior disc displacement with reduction (ADDwR), and 7 were from patients with anterior disc displacement without reduction (ADDwoR). There was no statistically significant difference in intensity of stain between groupings (p = 0.673). The results indicate a negative correlation between TMD and the expression of TLR-4.
- 25 March 2018
- Published by Taylor & Francis in Cranio®
- Vol. 37 (5) , 323-328
Immunohistochemical expression of TLR-4 in temporomandibular joint dysfunction
Toll-like receptor 4 (TLR-4) is a transmembrane protein involved in the innate immune system and has been implicated in the pathogenesis of temporomandibular joint dysfunction (TMD). The purpose of this study was to histologically examine the level of expression of TLR-4 relative to severity of TMD. Thirty-one human TMJ disc samples were immunostained for TLR-4 and evaluated for intensity of stain. Among the samples, 8 were control samples, 16 were from patients with anterior disc displacement with reduction (ADDwR), and 7 were from patients with anterior disc displacement without reduction (ADDwoR). There was no statistically significant difference in intensity of stain between groupings (p = 0.673). The results indicate a negative correlation between TMD and the expression of TLR-4.
- 1 May 2017
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 45 (5) , 768-774
Interleukin-6 expression in disc derangement of human temporomandibular joint and association with osteoarthrosis
- 1 May 2017
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 45 (5) , 768-774
Interleukin-6 expression in disc derangement of human temporomandibular joint and association with osteoarthrosis
- 26 April 2017
- Published by Taylor & Francis in Cranio®
- Vol. 36 (3) , 161-166
Expression of MMP-13 in human temporomandibular joint disc derangement and osteoarthritis
Objective: MMP-13 performs digestion of collagen, which is a primary component of the temporomandibular joint (TMJ) articular disc. This study evaluated the expression of MMP-13 in patients with anterior disc displacement with (ADDwR) and without reduction (ADDwoR), and in the presence of TMJ osteoarthrosis. Methods: Thirty-nine human temporomandibular joint disc samples were collected and divided in two ways: ADDwR (21 samples), ADDwoR (10 samples), and a control group (8 samples); and with osteoarthrosis (10 samples) and without osteoarthrosis (29 samples). Immunostaining of the TMJ discs was statistically compared between the groups. Results: There was no statistically significant difference for the area of MMP-13 immunostaining between the control group, ADDwR, and ADDwoR, nor between groups with and without osteoarthrosis. Conclusion: This study suggests MMP-13 is not significantly involved in collagen degradation in human TMJ disc displacement or osteoarthrosis.
- 26 April 2017
- Published by Taylor & Francis in Cranio®
- Vol. 36 (3) , 161-166
Expression of MMP-13 in human temporomandibular joint disc derangement and osteoarthritis
Objective: MMP-13 performs digestion of collagen, which is a primary component of the temporomandibular joint (TMJ) articular disc. This study evaluated the expression of MMP-13 in patients with anterior disc displacement with (ADDwR) and without reduction (ADDwoR), and in the presence of TMJ osteoarthrosis. Methods: Thirty-nine human temporomandibular joint disc samples were collected and divided in two ways: ADDwR (21 samples), ADDwoR (10 samples), and a control group (8 samples); and with osteoarthrosis (10 samples) and without osteoarthrosis (29 samples). Immunostaining of the TMJ discs was statistically compared between the groups. Results: There was no statistically significant difference for the area of MMP-13 immunostaining between the control group, ADDwR, and ADDwoR, nor between groups with and without osteoarthrosis. Conclusion: This study suggests MMP-13 is not significantly involved in collagen degradation in human TMJ disc displacement or osteoarthrosis.
- Open Access
- 1 January 2014
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 5 (11) , 796-799
Operative management of idiophatic myositis ossificans of lateral pterygoid muscle
INTRODUCTION: Myositis ossificans (MO) is characterized as heterotopic bone formation within muscle. MO rarely occurs in the head and neck region. Excision of the heterotopic bone is the standard treatment. This report summarizes a case of a 12-year old female with MO involving the lateral pterygoid muscle. The heterotopic bone was excised using an intraoral incision. Despite intensive physical therapy, the operation failed as evidenced by new bone formation in the area within three weeks of the operation. PRESENTATION OF CASE: A twelve years old female patient presenting with mouth opening of 10 mm, no facial asymmetry, and no jaw joint pain or other symptoms. Computer tomography (CT) exam was requested and revealed calcification of the left lateral pterygoid muscle. No other masticatory or head muscles showed any signs of calcification. The calcified muscle was completely removed beyond the ossified segment and a 35 mm mouth opening was achieved immediately after the procedure. One month after total bone structure removal (first surgery) the patient could not open her mouth anymore due to a significant calcified mass. DISCUSSION: The surgical technique used in this case avoided invasive gap arthroplasty to access lateral pterygoid muscle and anaesthetic scarring formation, by using an intraorally incision accessing the muscle directly. The authors of these study did not see any relation with the condylar dislocation that the patient had five years prior to the pathology, and they could not find any real cause for the myositis ossificans of lateral pterygoid muscle. CONCLUSION: The outcome of the surgical procedure was not successful, perhaps due to the expression of the disease, indicating the need to further physiologic and genetic studies to elucidate the aetiology of MO as well as to provide directions to an adequate treatment choice for such cases.
- 1 January 2014
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 5 (11) , 796-799
Open AccessOperative management of idiophatic myositis ossificans of lateral pterygoid muscle
INTRODUCTION: Myositis ossificans (MO) is characterized as heterotopic bone formation within muscle. MO rarely occurs in the head and neck region. Excision of the heterotopic bone is the standard treatment. This report summarizes a case of a 12-year old female with MO involving the lateral pterygoid muscle. The heterotopic bone was excised using an intraoral incision. Despite intensive physical therapy, the operation failed as evidenced by new bone formation in the area within three weeks of the operation. PRESENTATION OF CASE: A twelve years old female patient presenting with mouth opening of 10 mm, no facial asymmetry, and no jaw joint pain or other symptoms. Computer tomography (CT) exam was requested and revealed calcification of the left lateral pterygoid muscle. No other masticatory or head muscles showed any signs of calcification. The calcified muscle was completely removed beyond the ossified segment and a 35 mm mouth opening was achieved immediately after the procedure. One month after total bone structure removal (first surgery) the patient could not open her mouth anymore due to a significant calcified mass. DISCUSSION: The surgical technique used in this case avoided invasive gap arthroplasty to access lateral pterygoid muscle and anaesthetic scarring formation, by using an intraorally incision accessing the muscle directly. The authors of these study did not see any relation with the condylar dislocation that the patient had five years prior to the pathology, and they could not find any real cause for the myositis ossificans of lateral pterygoid muscle. CONCLUSION: The outcome of the surgical procedure was not successful, perhaps due to the expression of the disease, indicating the need to further physiologic and genetic studies to elucidate the aetiology of MO as well as to provide directions to an adequate treatment choice for such cases.